Rigel Pharmaceuticals (RIGL) EBIT (2010 - 2026)
Rigel Pharmaceuticals (RIGL) reported EBIT of $23.58 million for Q2 2026, down 61.4% from $61.1 million a year earlier but up 98.4% from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) EBIT (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Rigel Pharmaceuticals' EBIT came in at $87.05 million, down 16.8% year-over-year; for FY2025, it was $125.47 million, up 418.6% from FY2024.
- By year, EBIT came in at $24.19 million in FY2024, -$20.49 million in FY2023, -$55.55 million in FY2022 and -$12.5 million in FY2021.
- Five-year quarterly EBIT spans a low of -$26.26 million in Q1 2022 and a high of $61.1 million in Q2 2025.
- Year over year, EBIT gained in three of the last five quarters, with growth averaging 164.0%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.89 million (Q1 2026), $23.17 million (Q4 2025) and $28.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Rigel Pharmaceuticals | 896.55 Mn | 362.44 Mn | 70.18 Mn | 23.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.58 Mn |
| Mar 31, 2026 | 11.89 Mn |
| Dec 31, 2025 | 23.17 Mn |
| Sep 30, 2025 | 28.42 Mn |
| Jun 30, 2025 | 61.10 Mn |
| Mar 31, 2025 | 12.77 Mn |
| Dec 31, 2024 | 16.66 Mn |
| Sep 30, 2024 | 14.06 Mn |
| Jun 30, 2024 | 447,000.00 |
| Mar 31, 2024 | -6.97 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Sep 30, 2023 | -4.47 Mn |
| Jun 30, 2023 | -5.27 Mn |
| Mar 31, 2023 | -12.73 Mn |
| Dec 31, 2022 | 2.08 Mn |
| Sep 30, 2022 | -18.40 Mn |
| Jun 30, 2022 | -12.97 Mn |
| Mar 31, 2022 | -26.26 Mn |
| Dec 31, 2021 | -21.42 Mn |
| Sep 30, 2021 | -19.79 Mn |
API Access
Rigel Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();